News

Biogen and Apple to Research If Apple Watch/iPhone Can Be Used to Study Cognitive Health

Biotechnology company Biogen has announced a partnership with Apple to study the role the Apple Watch and iPhone might play in monitoring cognitive performance and screening for the decline in cognitive health.

The multi-year, observational research study will be launched later in 2021 and will enroll participants including young and aging adults with a range of cognitive performance. Driven by the powerful technology in Apple Watch and iPhone and Biogen’s in-depth knowledge of neuroscience, the study’s primary objectives are to develop digital biomarkers to help monitor cognitive performance over time and identify early signs of MCI.

For aging adults, cognitive health is becoming increasingly recognized as an important component of overall health. However, significant delays exist in identifying declines in cognitive health including MCI, which impacts approximately 15 – 20 percent of adults over the age of 65. The onset of symptoms is often subtle, ranging from being easily distracted to memory loss, and can take months to years before cognitive decline comes to the attention of health care providers.

As you might expect, the study will be privacy-focused, offering transparency, data security, and customer control.

The virtual study allows adult users across the aging lifespan to join. The study has been designed with customer privacy, control and transparency in mind as well as data security. Participants, who can stop taking part in the study at any time, will complete a detailed consent form listing the collected data types and how each may be used and shared. Data will be stored in an encrypted manner and in systems with strong security controls designed to protect the data.

“Working in collaboration with Biogen, we hope this study can help the medical community better understand a person’s cognitive performance by simply having them engage with their Apple Watch and ‌iPhone‌,” said Jeff Williams, Apple’s chief operating officer. “We’re looking forward to learning about the impact our technology can have in delivering better health outcomes through improved detection of declining cognitive health.”

Chris Hauk

Chris is a Senior Editor at Mactrast. He lives somewhere in the deep Southern part of America, and yes, he has to pump in both sunshine and the Internet.